Myasthenia Gravis
Background
Pathophysiology
- Auto-antibody to nicotinic ACh receptor (NAChR) at the neuromuscular junction.
- B and T cell involvement.
Epidemiology
- 1/8000 prevalence.
- 2 peaks: young females – associated with other autoimmune diseases (RA, SLE) and thymic hyperplasia – and old males – associated with thymic atrophy or thymoma (10%).
Signs and symptoms
- Extraocular: ptosis, diplopia. Presenting complaint in 50%.
- Bulbar: dysarthria/phonia/phagia.
- Face: myasthenic snarl on smiling.
- Neck
- Limb girdle i.e. proximal weakness.
- Trunk
Exacerbating factors:
- Intercurrent illness: infection, ↓K+.
- Over-treatment.
- Altered climate.
- Physiological stress: pregnancy, emotion, exercise.
- Drugs: gentamycin, tetracycline, opioids, quinine, Ξ²-blockers.
Signs:
- Fatiguability: cannot hold eyes in upward gaze for more than a few seconds, voice becomes quiet on counting to 50.
- Weak forced eye closure that is easily overcome.
- Reflexes, bulk, tone, and sensation all normal.
Differential diagnosis
- Polymyositis
- Multiple sclerosis.
- Motor neuron disease.
- Guillain BarrΓ© syndrome.
- Lambert-Eaton myasthenic syndrome.
- Botulism. Causes ↓ACh release at NMJ.
Investigations
- 90% sensitive, or 70% in ocular-only disease. May also be +ve in Lambert-Eaton, thymoma, or small cell lung cancer.
- If -ve, check MuSK Ab (+ve in ⅓), and anti-SM Ab.
Special tests:
- EMG, which should include repetitive nerve stimulation and single-fibre EMG.
- Ice test: ice pack applied to closed eyelid for 2-5 minutes → ptosis improves in MG.
- Tensilon test: tests response to sequential doses of short-acting IV cholinesterase inhibitor edrophonium, which should cause transient ↑power. No longer routine practice, and if it is done there should be resus facilities and atropine to hand.
CT thorax to look for thymus changes.
Management
- Long-term cholinesterase inhibitor e.g. pyridostigmine. Cholinergic side effects: salivation, lacrimation, sweats, miosis, diarrhoea and vomiting, colic.
- Immunosuppression for relapses: prednisolone, azathioprine, methotrexate, methylprednisolone IV, or plasma exchange.
- Thymectomy if thymoma present. Also beneficial in treatment-resistant MG even if thymoma absent.
Prognosis
- Often follows a relapsing-remitting course.
- Normal life expectancy for most with treatment.
Comments
Post a Comment
Comment OR Suggest any changes